BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 27440896)

  • 1. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
    Caine EA; Moncla LH; Ronderos MD; Friedrich TC; Osorio JE
    J Virol; 2016 Oct; 90(19):8592-604. PubMed ID: 27440896
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Caine EA; Osorio JE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of enterovirus 71 to adult interferon deficient mice.
    Caine EA; Partidos CD; Santangelo JD; Osorio JE
    PLoS One; 2013; 8(3):e59501. PubMed ID: 23527208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice.
    Wang W; Duo J; Liu J; Ma C; Zhang L; Wei Q; Qin C
    Microbes Infect; 2011 Sep; 13(10):862-70. PubMed ID: 21612764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.
    Meng T; Kwang J
    J Virol; 2014 May; 88(10):5803-15. PubMed ID: 24623423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
    Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single Mutation in the VP1 Gene of Enterovirus 71 Enhances Viral Binding to Heparan Sulfate and Impairs Viral Pathogenicity in Mice.
    Ke X; Zhang Y; Liu Y; Miao Y; Zheng C; Luo D; Sun J; Hu Q; Xu Y; Wang H; Zheng Z
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32823486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Positively Charged Residues in Enterovirus 71 Capsid Protein VP1 Essential for Production of Infectious Particles.
    Yuan S; Li G; Wang Y; Gao Q; Wang Y; Cui R; Altmeyer R; Zou G
    J Virol; 2016 Jan; 90(2):741-52. PubMed ID: 26512078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in VP1 and 5'-UTR affect enterovirus 71 virulence.
    Chang CK; Wu SR; Chen YC; Lee KJ; Chung NH; Lu YJ; Yu SL; Liu CC; Chow YH
    Sci Rep; 2018 Apr; 8(1):6688. PubMed ID: 29703921
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Meng T; Jia Q; Wong SM; Chua KB
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on enterovirus 71 infection.
    Huang PN; Shih SR
    Curr Opin Virol; 2014 Apr; 5():98-104. PubMed ID: 24727707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
    Lyu K; He YL; Li HY; Chen R
    J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the association of hand, foot and mouth disease and enterovirus 71/CA16 among children in Beijing, 2007].
    Zhu RN; Qian Y; Deng J; Xing JF; Zhao LQ; Wang F; Liao B; Ren XX; Li Y; Zhang Q; Li J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):1004-8. PubMed ID: 18399150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of enterovirus 71 and coxsackievirus A16 from children with hand, foot and mouth disease in Shanghai, 2002].
    Yang ZH; Zhu QR; Li XZ; Wang XH; Wang JS; Hu JY; Tang W; Cui AL
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):648-52. PubMed ID: 16191294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enterovirus 71 infection in children with hand, foot, and mouth disease in Shanghai, China: epidemiology, clinical feature and diagnosis.
    Wang Y; Zou G; Xia A; Wang X; Cai J; Gao Q; Yuan S; He G; Zhang S; Zeng M; Altmeyer R
    Virol J; 2015 Jun; 12():83. PubMed ID: 26036928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
    Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
    Front Immunol; 2019; 10():2564. PubMed ID: 31787970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research into the Pathogenicity of Enterovirus 71].
    Sun L; Wen H; Wang Z
    Bing Du Xue Bao; 2015 Mar; 31(2):192-6. PubMed ID: 26164947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
    Li B; Yue Y; Zhang Y; Yuan Z; Li P; Song N; Lin W; Liu Y; Gu L; Meng H
    Front Cell Infect Microbiol; 2017; 7():26. PubMed ID: 28217559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.
    Huang SW; Wang YF; Yu CK; Su IJ; Wang JR
    Virology; 2012 Jan; 422(1):132-43. PubMed ID: 22078110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
    Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.